Lung cancer mutation detection kit

Create PDF

December 2018—Precipio launched a new ICEme kit using the company’s proprietary Ice-Cold PCR technology.

The kit provides physicians with the ability to use a liquid biopsy to identify patients eligible for tyrosine kinase inhibitor therapies through analysis of tumor DNA for these EGFR mutations.